Osteopontin: An early innate immune marker of Escherichia coli mastitis harbors genetic polymorphisms with possible links with resistance to mastitis

BMC Genomics

Volumn 10, Issue , 2009, Pages 444-

  Alain, Karin ^a,b   Karrow, Niel A ^c   Thibault, Catherine ^a   St Pierre, Jessika ^a,b   Lessard, Martin ^a   Bissonnette, Nathalie ^a,b  

^a SHERBROOKE RESEARCH AND DEVELOPMENT CENTRE   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FAT; IKAROS TRANSCRIPTION FACTOR; OSTEOPONTIN; PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DAIRY CATTLE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; EPSTEIN BARR VIRUS; ESCHERICHIA COLI INFECTION; FEMALE; GENETIC ASSOCIATION; HAPLOTYPE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INNATE IMMUNITY; LACTATION; MASTITIS; MILK PRODUCTION; MILK YIELD; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC CELL; TH1 CELL; ANIMAL; ANIMAL DISEASE; BREEDING; CATTLE; CATTLE DISEASE; CHEMISTRY; DNA SEQUENCE; ESCHERICHIA COLI; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MILK; MOLECULAR GENETICS; UDDER;

ESCHERICHIA COLI; HUMAN HERPESVIRUS 4;

ANIMALS; BASE SEQUENCE; BREEDING; CATTLE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HAPLOTYPES; IMMUNITY, INNATE; LACTATION; MAMMARY GLANDS, ANIMAL; MASTITIS, BOVINE; MILK; MOLECULAR SEQUENCE DATA; OSTEOPONTIN; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 70350451734     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-10-444     Document Type: Article

References (73)

1. Bar D, Tauer LW, Bennett G, González RN, Hertl JA, Schukken YH, Schulte HF, Welcome FL, Gröhn YT. The cost of generic clinical mastitis in dairy cows as estimated by using dynamic programming. J Dairy Sci 2008, 91(6):2205-2214. 10.3168/jds.2007-0573, 18487643.
2. Bradley A. Bovine mastitis: an evolving disease. The Veterinary Journal 2002, 164(2):116-128. 10.1053/tvjl.2002.0724, 12359466.
3. Huijps K, Lam TJ, Hogeveen H. Costs of mastitis: facts and perception. The Journal of Dairy Research 2008, 75(1):113-120. 10.1017/S0022029907002932, 18226298.
4. Sordillo LM, Shafer-Weaver K, DeRosa D. Immunobiology of the mammary gland. J Dairy Sci 1997, 80(8):1851-1865.
5. Rainard P, Riollet C. Innate immunity of the bovine mammary gland. Vet Res 2006, 37(3):369-400. 10.1051/vetres:2006007, 16611554.
6. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. Journal of immunology (Baltimore, Md: 1950) 2000, 165(2):618-622.
7. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004, 4(7):499-511. 10.1038/nri1391, 15229469.
8. Nagai S, Hashimoto S, Yamashita T, Toyoda N, Satoh T, Suzuki T, Matsushima K. Comprehensive gene expression profile of human activated T(h)1- and T(h)2-polarized cells. Int Immunol 2001, 13(3):367-376. 10.1093/intimm/13.3.367, 11222506.
9. Concha C. Cell types and their immunological functions in bovine mammary tissues and secretions--a review of the literature. Nord Vet Med 1986, 38(5):257-272.
10. Lahouassa H, Moussay E, Rainard P, Riollet C. Differential cytokine and chemokine responses of bovine mammary epithelial cells to Staphylococcus aureus and Escherichia coli. Cytokine 2007, 38(1):12-21. 10.1016/j.cyto.2007.04.006, 17532224.
11. Peveri P, Walz A, Dewald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. The Journal of experimental medicine 1988, 167(5):1547-1559. 10.1084/jem.167.5.1547, 2188939, 2835419.
12. Rupp R, Hernandez A, Mallard BA. Association of bovine leukocyte antigen (BoLA) DRB3.2 with immune response, mastitis, and production and type traits in Canadian Holsteins. J Dairy Sci 2007, 90(2):1029-1038.
13. Sordillo LM, Streicher KL. Mammary gland immunity and mastitis susceptibility. J Mammary Gland Biol Neoplasia 2002, 7(2):135-146. 10.1023/A:1020347818725, 12463736.
14. Begley N, Buckley F, Pierce KM, Fahey AG, Mallard BA. Differences in udder health and immune response traits of Holstein-Friesians, Norwegian Reds, and their crosses in second lactation. J Dairy Sci 2009, 92(2):749-757. 10.3168/jds.2008-1356, 19164687.
15. Wilson DJ, Grohn YT, Bennett GJ, Gonzalez RN, Schukken YH, Spatz J. Comparison of J5 vaccinates and controls for incidence, etiologic agent, clinical severity, and survival in the herd following naturally occurring cases of clinical mastitis. J Dairy Sci 2007, 90(9):4282-4288. 10.3168/jds.2007-0160, 17699047.
16. Wilson DJ, Mallard BA, Burton JL, Schukken YH, Grohn YT. Milk and serum J5-specific antibody responses, milk production change, and clinical effects following intramammary Escherichia coli challenge for J5 vaccinate and control cows. Clin Vaccine Immunol 2007, 14(6):693-699. 10.1128/CVI.00104-07, 1951090, 17460115.
17. Wilson DJ, Mallard BA, Burton JL, Schukken YH, Grohn YT. Association of Escherichia coli J5-specific serum antibody responses with clinical mastitis outcome for J5 vaccinate and control dairy cattle. Clin Vaccine Immunol 2009, 16(2):209-217. 10.1128/CVI.00324-08, 2643543, 19052158.
18. Nonaka M, Kimura A. Genomic view of the evolution of the complement system. Immunogenetics 2006, 58(9):701-713. 10.1007/s00251-006-0142-1, 2480602, 16896831.
19. Jault C, Pichon L, Chluba J. Toll-like receptor gene family and TIR-domain adapters in Danio rerio. Mol Immunol 2004, 40(11):759-771. 10.1016/j.molimm.2003.10.001, 14687933.
20. Kadarmideen HN, von Rohr P, Janss LL. From genetical genomics to systems genetics: potential applications in quantitative genomics and animal breeding. Mamm Genome 2006, 17(6):548-564. 10.1007/s00335-005-0169-x, 16783637.
21. Olde Riekerink RG, Barkema HW, Kelton DF, Scholl DT. Incidence rate of clinical mastitis on Canadian dairy farms. J Dairy Sci 2008, 91(4):1366-1377. 10.3168/jds.2007-0757, 18349229.
22. Rupp R, Boichard D. Genetics of resistance to mastitis in dairy cattle. Vet Res 2003, 34(5):671-688. 10.1051/vetres:2003020, 14556700.
23. Mrode RA, Swanson GJT. Estimation of genetic parameters for somatic cell count in the first three lactations using random regression. Livestock Production Science 2003, 79(2-3):239-247.
24. Heringstad B, Klemetsdal G, Ruane J. Selection for mastitis resistance in dairy cattle: a review with focus on the situation in the Nordic countries. Livestock Production Science 2000, 64(2-3):95-106.
25. Rupp R, Bergonier D, Dion S, Hygonenq MC, Aurel MR, Robert-Granie C, Foucras G. Response to somatic cell count-based selection for mastitis resistance in a divergent selection experiment in sheep. J Dairy Sci 2009, 92(3):1203-1219. 10.3168/jds.2008-1435, 19233814.
26. Luttinen A, Juga J. Genetic relationship between milk yield, somatic cell count, mastitis, milkability and leakage in Finnish dairy cattle. Interbull 1997, 15:78-83.
27. Poso J, Mantysaari EA. Relationships between clinical mastitis, somatic cell score, and production for the first three lactations of Finnish Ayrshire. J Dairy Sci 1996, 79(7):1284-1291.
28. Rupp R, Boichard D. Genetic parameters for clinical mastitis, somatic cell score, production, udder type traits, and milking ease in first lactation Holsteins. J Dairy Sci 1999, 82(10):2198-2204.
29. Nielsen US, Pedersen GA, Pedersen J, Jensen J. Genetic correlations among health traits in different lactations. Interbull 1997, 15:68-77.
30. de Haas Y, Ouweltjes W, ten Napel J, Windig JJ, de Jong G. Alternative somatic cell count traits as mastitis indicators for genetic selection. J Dairy Sci 2008, 91(6):2501-2511. 10.3168/jds.2007-0459, 18487674.
31. Heringstad B, Sehested E, Steine T. Short communication: correlated selection responses in somatic cell count from selection against clinical mastitis. J Dairy Sci 2008, 91(11):4437-4439. 10.3168/jds.2008-1330, 18946151.
32. Patarca R, Freeman GJ, Singh RP, Wei FY, Durfee T, Blattner F, Regnier DC, Kozak CA, Mock BA, Morse HC. Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. The Journal of experimental medicine 1989, 170(1):145-161. 10.1084/jem.170.1.145, 2189370, 2787378.
33. Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M, Pedotti R. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001, 294(5547):1731-1735. 10.1126/science.1062960, 11721059.
34. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. The Journal of clinical investigation 2001, 107(9):1055-1061. 10.1172/JCI12980, 209291, 11342566.
35. Chabas D. [Osteopontin, a multi-faceted molecule]. Medecine Science 2005, 21(10):832-838.
36. Konno S, Eckman JA, Plunkett B, Li X, Berman JS, Schroeder J, Huang SK. Interleukin-10 and Th2 cytokines differentially regulate osteopontin expression in human monocytes and dendritic cells. J Interferon Cytokine Res 2006, 26(8):562-567. 10.1089/jir.2006.26.562, 16881866.
37. Wang KX, Denhardt DT. Osteopontin: Role in immune regulation and stress responses. Cytokine Growth Factor Rev 2008, 19(5-6):562-567.
38. Campbell TM, Wong WT, Mackie EJ. Establishment of a model of cortical bone repair in mice. Calcif Tissue Int 2003, 73(1):49-55. 10.1007/s00223-002-2120-4, 14506954.
39. Giachelli CM, Liaw L, Murry CE, Schwartz SM, Almeida M. Osteopontin expression in cardiovascular diseases. Ann N Y Acad Sci 1995, 760:109-126. 10.1111/j.1749-6632.1995.tb44624.x, 7785890.
40. Singhal H, Bautista DS, Tonkin KS, O'Malley FP, Tuck AB, Chambers AF, Harris JF. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clinical cancer research: an official journal of the American Association for Cancer Research 1997, 3(4):605-611.
41. Plumer A, Duan H, Subramaniam S, Lucas FL, Miesfeldt S, Ng AK, Liaw L. Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer. BMC Cancer 2008, 8:38. 10.1186/1471-2407-8-38, 2259319, 18237408.
42. Weber GF, Zawaideh S, Hikita S, Kumar VA, Cantor H, Ashkar S. Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J Leukoc Biol 2002, 72(4):752-761.
43. Schnabel RD, Kim JJ, Ashwell MS, Sonstegard TS, Van Tassell CP, Connor EE, Taylor JF. Fine-mapping milk production quantitative trait loci on BTA6: analysis of the bovine osteopontin gene. Proc Natl Acad Sci USA 2005, 102(19):6896-6901. 10.1073/pnas.0502398102, 1100795, 15867146.
44. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, Rittling SR, Denhardt DT, Glimcher MJ, Cantor H. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000, 287(5454):860-864. 10.1126/science.287.5454.860, 10657301.
45. Higashibata Y, Sakuma T, Kawahata H, Fujihara S, Moriyama K, Okada A, Yasui T, Kohri K, Kitamura Y, Nomura S. Identification of promoter regions involved in cell- and developmental stage-specific osteopontin expression in bone, kidney, placenta, and mammary gland: an analysis of transgenic mice. J Bone Miner Res 2004, 19(1):78-88. 10.1359/jbmr.2004.19.1.78, 14753740.
46. Jones KA, Kadonaga JT, Rosenfeld PJ, Kelly TJ, Tjian R. A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell 1987, 48(1):79-89. 10.1016/0092-8674(87)90358-8, 3024847.
47. Yokono M, Saegusa N, Matsushita K, Sugiura Y. Unique DNA binding mode of the N-terminal zinc finger of transcription factor Sp1. Biochemistry (Mosc) 1998, 37(19):6824-6832.
48. Hummelshoj T, Ryder LP, Madsen HO, Odum N, Svejgaard A. A functional polymorphism in the Eta-1 promoter is associated with allele specific binding to the transcription factor Sp1 and elevated gene expression. Mol Immunol 2006, 43(7):980-986. 10.1016/j.molimm.2005.05.012, 16009426.
49. Quirion MR, Gregory GD, Umetsu SE, Winandy S, Brown MA. Cutting edge: Ikaros is a regulator of Th2 cell differentiation. J Immunol 2009, 182(2):741-745.
50. Black AR, Black JD, Azizkhan-Clifford J. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 2001, 188(2):143-160. 10.1002/jcp.1111, 11424081.
51. Suske G. The Sp-family of transcription factors. Gene 1999, 238(2):291-300. 10.1016/S0378-1119(99)00357-1, 10570957.
52. Gill G, Pascal E, Tseng ZH, Tjian R. A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. Proc Natl Acad Sci USA 1994, 91(1):192-196. 10.1073/pnas.91.1.192, 42912, 8278363.
53. Sodek J, Ganss B, McKee MD. Osteopontin. Crit Rev Oral Biol Med 2000, 11(3):279-303. 10.1177/10454411000110030101, 11021631.
54. Zetterqvist AV, Ohman JN, de Frutos Garcia S, McGuire PG, Bosc LG, Gomez MF. Hyperglycemia activates the Ca2+/calcineurin-dependent transcription factor NFAT (Nuclear Factor of Activated T-Cells) in retinal microvessels in vivo. The FASEB journal 2008, 22(1_MeetingAbstracts):1148.
55. Li X, O'Regan AW, Berman JS. IFN-gamma induction of osteopontin expression in human monocytoid cells. J Interferon Cytokine Res 2003, 23(5):259-265. 10.1089/107999003321829971, 12804068.
56. Oviedo-Boyso J, Valdez-Alarcon JJ, Cajero-Juarez M, Ochoa-Zarzosa A, Lopez-Meza JE, Bravo-Patino A, Baizabal-Aguirre VM. Innate immune response of bovine mammary gland to pathogenic bacteria responsible for mastitis. J Infect 2007, 54(4):399-409. 10.1016/j.jinf.2006.06.010, 16882453.
57. Riollet C, Rainard P, Poutrel B. Differential induction of complement fragment C5a and inflammatory cytokines during intramammary infections with Escherichia coli and Staphylococcus aureus. Clin Diagn Lab Immunol 2000, 7(2):161-167. 95843, 10702487.
58. Majoros WH, Ohler U. Spatial preferences of microRNA targets in 3' untranslated regions. BMC Genomics 2007, 8:152. 10.1186/1471-2164-8-152, 1904200, 17555584.
59. Gomez-Ambrosi J, Catalan V, Ramirez B, Rodriguez A, Colina I, Silva C, Rotellar F, Mugueta C, Gil MJ, Cienfuegos JA. Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab 2007, 92(9):3719-3727. 10.1210/jc.2007-0349, 17595250.
60. Ichikawa H, Imano M, Takeyama Y, Shiozaki H, Ohyanagi H. Involvement of osteopontin as a core protein in cholesterol gallstone formation. J Hepatobiliary Pancreat Surg 2009, 16(2):197-203. 10.1007/s00534-009-0043-4, 19214371.
61. Cancel AM, Chapman DA, Killian GJ. Osteopontin is the 55-kilodalton fertility-associated protein in Holstein bull seminal plasma. Biol Reprod 1997, 57(6):1293-1301. 10.1095/biolreprod57.6.1293, 9408233.
62. Erikson DW, Way AL, Chapman DA, Killian GJ. Detection of osteopontin on Holstein bull spermatozoa, in cauda epididymal fluid and testis homogenates, and its potential role in bovine fertilization. Reproduction 2007, 133(5):909-917. 10.1530/REP-06-0228, 17616721.
63. Lessard M, Gagnon N, Godson DL, Petit HV. Influence of parturition and diets enriched in n-3 or n-6 polyunsaturated fatty acids on immune response of dairy cows during the transition period. J Dairy Sci 2004, 87(7):2197-2210.
64. Dosogne H, Vangroenweghe F, Mehrzad J, Massart-Leen AM, Burvenich C. Differential leukocyte count method for bovine low somatic cell count milk. J Dairy Sci 2003, 86(3):828-834.
65. Wellnitz O, Reith P, Haas SC, Meyer HHD. Immune relevant gene expression of mammary epithelial cells and their influence on leukocyte chemotaxis in response to different mastitis pathogens. Vet Med (Praha) 2006, 51(4):125-132.
66. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408. 10.1006/meth.2001.1262, 11846609.
67. Nadesalingam J, Plante Y, Gibson JP. Detection of QTL for milk production on Chromosomes 1 and 6 of Holstein cattle. Mamm Genome 2001, 12(1):27-31. 10.1007/s003350010232, 11178740.
68. Leyva-Baca I, Schenkel F, Martin J, Karrow NA. Polymorphisms in the 5' upstream region of the CXCR1 chemokine receptor gene, and their association with somatic cell score in Holstein cattle in Canada. J Dairy Sci 2008, 91(1):407-417. 10.3168/jds.2007-0142, 18096965.
69. Rincon G, Medrano JF. Single nucleotide polymorphism genotyping of bovine milk protein genes using the tetra-primer ARMS-PCR. J Anim Breed Genet 2003, 120(5):331-337.
70. Ye S, Dhillon S, Ke X, Collins AR, Day IN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001, 29(17):E88-88. 10.1093/nar/29.17.e88, 55900, 11522844.
71. Zeng ZB, Wang T, Zou W. Modeling quantitative trait Loci and interpretation of models. Genetics 2005, 169(3):1711-1725. 10.1534/genetics.104.035857, 1449562, 15654105.
72. Boettcher PJ, Pagnacco G, Stella A. A Monte Carlo approach for estimation of haplotype probabilities in half-sib families. J Dairy Sci 2004, 87(12):4303-4310.
73. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265. 10.1093/bioinformatics/bth457, 15297300.